INTRODUCTION
Pancreatic cancer is the ninth most common malignant disease, and is the fifth ranked cause of cancer death in South Korea. Furthermore, advances in surgical and medical therapies have had little impact on the mortality rate of pancreatic cancer, and its 5-year survival rate after curative resection remains dismally low at 10 to 15%. In addition, the mechanisms of local tumor invasion and an early systemic dissemination at the molecular level in pancreatic cancer have not been completely elucidated.
The cancer stem cell (CSC) hypothesis may provide an understanding of cancer development and progression, and a new perspective as to how to develop therapies to treat cancer. CSCs constitute only a small proportion of cancer cells and are capable of self-renewal, differentiation, and tumorigenesis [1] . Research on the existence of CSCs was first undertaken in the context of human acute myeloid leukemia. However, recently studies on the cell surface marker expressions of CSCs, such as, CD133, CD44, CD24, and epithelial-specific antigen (ESA), have reported their involvements in solid malignancies of the breast, brain, prostate, and ovary [2] [3] [4] [5] [6] [7] [8] [9] .
To date, little study has been conducted on CSCs in pancreatic cancer, and thus, we undertook to determine the significances of cell surface markers, namely, CD133, CD44, and CD24, on the CSCs of pancreatic cancer cells.
METHODS

Cell culture
The pancreatic cell lines Capan-1, Mia-Paca-2, and During autopsies tumor dimensions and volumes, and the presence of any metastatic lesion were noted. Tissues were fixed in formaldehyde and hematoxylin and eosin stain 
Flow cytometry
RESULTS
Cell surface markers
Cell surface marker expressions were analyzed by CD133CD44＋CD24± and SNU-410 CD133-CD44＋
CD24- (Table 1) .
Tumorigenicity
To However, Capan-1 tumor volumes were seven times larger than Mia-Paca-2 tumor volumes ( Table 2 , Fig. 3) . In order to identify differences between Capan-1 and MiaPaca-2, NOD/SCID mice were injected with 2 × 10 5 or 2 × 
Origins of xenograft explants
DISCUSSION
Stem cells reside at the apex of the hierarchical structure that describes the generation of mature cells for particular thesurgery.or.kr it was reported that CSCs are present in acute leukemia [3, 6] , and in solid malignancies, such as, breast [2] , brain [4, 5, 8] , prostate [7] and ovary cancer [9] . [22] . In a study of pancreatic cancer cells, Hermann et al. [21] reported an overlap of 14% between CD44＋CD24＋
ESA＋ and CD133＋ pancreatic cancer cells, but unfortunately, no comparison of tumorigenicity was made.
Further in vivo tumorigenicity experiments will need to be performed to ascertain if CD44＋CD24＋ESA＋ and CD133＋ pancreatic cancer cells represent distinct CSC populations, or if a pancreatic cancer cell population ex-pressing combination of markers is more enriched for CSC function [12, 21] .
In the present study, we analyzed pancreatic cancer cell lines as for the expressions of CD133, CD44, and CD24, that is, all of the known cell surface markers of CSCs, and these cell lines were also compared with respect to tumorigenicity. Capan-1, which metastasizes to the liver, was only positive for CD133 and CD44 and these two markers may be expressed in the same CSC populations.
We 
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